Royal Bank of Canada
PAVMZ

Royal Bank of Canada’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Royal Bank of Canada’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200
Closed – – 6995
2020
Q2 		$0 Hold
200
– – ﹤0.01% 6965
2020
Q1 		$0 Hold
200
– – ﹤0.01% 7104
2019
Q4 		$0 Buy
+200
New +$63 ﹤0.01% 7191

Other funds holding PAVMZ

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return

Royal Bank of Canada's PAVMZ Position: Q3 2020 in Review

Royal Bank of Canada sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q3 2020, closing a stake of 200 shares.

Royal Bank of Canada first reported a position in PAVMZ in Q4 2019 and held it in 3 quarters. The position peaked at $0 in Q2 2020. 6 funds tracked by Wall St. Rank hold PAVMZ as of Q3 2020.

  • Royal Bank of Canada reported no remaining PAVmed Inc. Series Z Warrant position as of Q3 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 200 PAVmed Inc. Series Z Warrant shares in Q3 2020.
  • Royal Bank of Canada first reported a position in PAVmed Inc. Series Z Warrant in Q4 2019 and held it in 3 quarters.
  • Royal Bank of Canada's PAVmed Inc. Series Z Warrant position peaked at $0 in Q2 2020.
  • 6 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q3 2020.

Based on Royal Bank of Canada's 13F filing for Q3 2020, filed 16 Nov 2020.